Rosuvastatin Calcium Tablet 20mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
LightPharmtech Co., Ltd.
MFDS item code 201904763 · Approved 2019.07.16
This product's status changed to Expired on 2024.07.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is used to treat various diseases related to hypercholesterolemia. First, it is used as an adjunct when dietary measures and exercise do not adequately control primary hypercholesterolemia and mixed dyslipidemia. It also helps patients with homozygous familial hypercholesterolemia as an adjunct to diet or other lipid-lowering therapies. It lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis. This medicine is also used to reduce cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia. It is used as an adjunct to dietary measures in patients with primary dysbetalipoproteinemia, and helps in reducing the risk of cardiovascular diseases such as stroke, myocardial infarction, and arterial revascularization. Therefore, it is used to improve various factors associated with dyslipidemia and cardiovascular disease risk.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 mg daily. 3. Older patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: The safety and efficacy of this medicine have not been established in children under 10 years of age.
This medicine should not be administered to certain patients such as those who are allergic to it, those with severely impaired liver function, individuals with muscle diseases, severely impaired renal function patients, and those who are pregnant or breastfeeding. Additionally, it should be administered with caution to patients at high risk of muscle-related side effects or with a history of liver disease, and regular monitoring of liver function and muscle conditions is important during treatment. This medicine may cause musculoskeletal adverse reactions, such as muscle pain, myopathy, and rarely severe muscle destruction known as rhabdomyolysis. If muscle pain or weakness symptoms occur, healthcare providers must be informed immediately. Liver dysfunction, gastrointestinal disturbances, headache, dizziness, skin rash and other side effects have been reported, so caution is needed if these symptoms appear. This medicine may interact with specific drugs, raising blood concentration and increasing the risk of side effects. Therefore, it is crucial to consult a doctor or pharmacist before concomitantly using other medications. Women of childbearing potential should take appropriate contraceptive measures and should not use this medicine during pregnancy. In case of overdose, since there is no specific antidote, treatment according to symptoms along with monitoring of liver function and muscle enzyme levels is necessary. This medicine is not expected to significantly affect the ability to drive or operate machinery; however, due to the possibility of dizziness, caution is advised.
Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms, drug-induced pemphigus, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, forgetfulness, amnesic syndrome, memory disorders, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is best to store at room temperature between 1°C and 30°C.
Pink round film-coated tablet
30 tablets/box [(15 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
LightPharmtech Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.